New and Improved: The Latest Research in Disease Screening
New ideas and innovations look beyond conventional screening options to facilitate improved disease diagnosis and patient outcomes
Emerging Tests-dtet
Generalizing Genomics Learning
A new NIH network aims to remove barriers and share knowledge to drive more widespread adoption of genomics in clinical settings
When Is Genome Sequencing Advisable?
With patient and provider demand for WGS on the rise, what should laboratorians know about ordering and interpreting this testing?
New Blood-Based PTSD Biomarkers Revealed
A simple blood test may help screen, identify, intervene, treat, monitor, and eventually, prevent PTSD.
New Device Predicts the Efficacy of Hypnosis Treatment for Pain
The inexpensive POC device is a biosensor that performs COMT genotyping as a biomarker for hypnotizability.
Simplifying Antidepressant Quantification in Clinical Labs
A recent study provides insights on how to use automation and only 20 μL of a serum sample to quantify blood levels of antidepressants.
Bringing Multi-Cancer Tests Closer to Reality
A new method for early detection of 14 cancer types based on glycosaminoglycan profiles shows promise.
Easier, Noninvasive Diagnosis of Neurological Disorders
More companies have begun offering neurofilament light chain blood tests as a cost-effective alternative to conventional methods.
Improving the Chances of Early Breast Cancer Detection in High-Risk Patients
A new test targeting changes in serum proteins can detect breast cancer up to two years before the condition would normally be diagnosed.
New Urine Test Can Detect Synthetic Cannabinoids in Marijuana
Recent study shows the new test can identify a widespread and dangerous class of synthetic cannabinoids called BZO-CHMOXIZID.
CMS to Create New Breakthrough Device Medicare Coverage Rule
The rule would ensure Medicare coverage of newly approved breakthrough devices, but have stricter evidence standards.
Blood Test Can Reliably Predict Patient Risk of Long COVID
Research offers new evidence that a test targeting blood-based biomarkers can predict someone’s risk of developing long COVID.
Is an Antibody Test for Early Detection of Lyme Disease Feasible?
Recent study suggests a new test may help doctors detect Lyme disease during the early stages when treatment is likely to be more effective.
